BR0010449A - 14beta-h-sterols, pharmaceutical compositions comprising the same and use of these derivatives for the preparation of meiosis regulating drugs - Google Patents
14beta-h-sterols, pharmaceutical compositions comprising the same and use of these derivatives for the preparation of meiosis regulating drugsInfo
- Publication number
- BR0010449A BR0010449A BR0010449-3A BR0010449A BR0010449A BR 0010449 A BR0010449 A BR 0010449A BR 0010449 A BR0010449 A BR 0010449A BR 0010449 A BR0010449 A BR 0010449A
- Authority
- BR
- Brazil
- Prior art keywords
- 14beta
- sterols
- preparation
- pharmaceutical compositions
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Patente de Invenção: "14BETA-H-ESTERóIS, COMPOSIçõES FARMACêUTICAS QUE COMPREENDEM OS MESMOS E USO DESTES DERIVADOS PARA A PREPARAçãO DE MEDICAMENTOS REGULADORES DA MEIOSE". A presente invenção refere-se a 14beta-H-esteróis, farmaceuticamente ativos, a composições farmacêuticas que compreendem as mesmas e ao uso destes novos compostos para a preparação de medicamentos. Mais particularmente foi descoberto que os 14beta-H-esteróis da invenção podem ser usados para regular a meiose.Invention Patent: "14BETA-H-STEROLS, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THE SAME AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATORY DRUGS". The present invention relates to 14beta-H-sterols, pharmaceutically active, to pharmaceutical compositions comprising them and to the use of these new compounds for the preparation of medicaments. More particularly it has been found that the 14beta-H-sterols of the invention can be used to regulate meiosis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99250153 | 1999-05-10 | ||
PCT/EP2000/004092 WO2000068245A1 (en) | 1999-05-10 | 2000-05-05 | 14β-H-STEROLS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0010449A true BR0010449A (en) | 2002-02-13 |
Family
ID=8241145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0010449-3A BR0010449A (en) | 1999-05-10 | 2000-05-05 | 14beta-h-sterols, pharmaceutical compositions comprising the same and use of these derivatives for the preparation of meiosis regulating drugs |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1177205A1 (en) |
JP (1) | JP2002544136A (en) |
KR (1) | KR20020013541A (en) |
CN (1) | CN1350543A (en) |
AU (1) | AU4756100A (en) |
BG (1) | BG106093A (en) |
BR (1) | BR0010449A (en) |
CA (1) | CA2373442A1 (en) |
CZ (1) | CZ20013981A3 (en) |
EA (1) | EA200101157A1 (en) |
EE (1) | EE200100592A (en) |
HU (1) | HUP0201098A2 (en) |
IL (1) | IL145373A0 (en) |
NO (1) | NO20015488L (en) |
PL (1) | PL352029A1 (en) |
SK (1) | SK16212001A3 (en) |
WO (1) | WO2000068245A1 (en) |
ZA (1) | ZA200110073B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012044817A2 (en) * | 2010-10-01 | 2012-04-05 | Indiana University Research And Technology Corporation | Process for preparing delta-7,9(11) steroids from ganoderma lucidum and analogs thereof |
WO2021046678A1 (en) * | 2019-09-09 | 2021-03-18 | 邦泰生物工程(深圳)有限公司 | Method for synthesising chenodeoxycholic acid and application therefor |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4202891A (en) * | 1977-05-16 | 1980-05-13 | Kandutsch Andrew A | 15-Oxygenated sterol compounds and the use of such compounds to inhibit the biosynthesis of sterols |
PL322106A1 (en) * | 1995-03-06 | 1998-01-05 | Novo Nordisk As | Meiosis stimulation |
WO1999058549A1 (en) * | 1998-05-13 | 1999-11-18 | Novo Nordisk A/S | Meiosis regulating compounds |
-
2000
- 2000-05-05 JP JP2000616219A patent/JP2002544136A/en active Pending
- 2000-05-05 EE EEP200100592A patent/EE200100592A/en unknown
- 2000-05-05 CN CN00807346A patent/CN1350543A/en active Pending
- 2000-05-05 HU HU0201098A patent/HUP0201098A2/en unknown
- 2000-05-05 PL PL00352029A patent/PL352029A1/en not_active Application Discontinuation
- 2000-05-05 BR BR0010449-3A patent/BR0010449A/en not_active Application Discontinuation
- 2000-05-05 WO PCT/EP2000/004092 patent/WO2000068245A1/en not_active Application Discontinuation
- 2000-05-05 EA EA200101157A patent/EA200101157A1/en unknown
- 2000-05-05 CZ CZ20013981A patent/CZ20013981A3/en unknown
- 2000-05-05 SK SK1621-2001A patent/SK16212001A3/en unknown
- 2000-05-05 EP EP00929510A patent/EP1177205A1/en not_active Withdrawn
- 2000-05-05 CA CA002373442A patent/CA2373442A1/en not_active Abandoned
- 2000-05-05 IL IL14537300A patent/IL145373A0/en unknown
- 2000-05-05 AU AU47561/00A patent/AU4756100A/en not_active Abandoned
- 2000-05-05 KR KR1020017014304A patent/KR20020013541A/en not_active Application Discontinuation
-
2001
- 2001-11-09 NO NO20015488A patent/NO20015488L/en not_active Application Discontinuation
- 2001-11-09 BG BG106093A patent/BG106093A/en unknown
- 2001-12-06 ZA ZA200110073A patent/ZA200110073B/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO20015488L (en) | 2002-01-09 |
HUP0201098A2 (en) | 2002-08-28 |
EP1177205A1 (en) | 2002-02-06 |
KR20020013541A (en) | 2002-02-20 |
SK16212001A3 (en) | 2002-02-05 |
WO2000068245A1 (en) | 2000-11-16 |
CZ20013981A3 (en) | 2002-02-13 |
AU4756100A (en) | 2000-11-21 |
EA200101157A1 (en) | 2002-06-27 |
ZA200110073B (en) | 2003-03-06 |
CA2373442A1 (en) | 2000-11-16 |
CN1350543A (en) | 2002-05-22 |
IL145373A0 (en) | 2002-06-30 |
PL352029A1 (en) | 2003-07-28 |
BG106093A (en) | 2002-05-31 |
EE200100592A (en) | 2003-02-17 |
JP2002544136A (en) | 2002-12-24 |
NO20015488D0 (en) | 2001-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2162927T3 (en) | FORMULATION FOR APPLICATION BY INHALATION. | |
BR9807974A (en) | Pharmaceutical composition for prolonged release of an erythromycin derivative in the gastrointestinal environment, and process for using the same | |
KR950007841A (en) | Sustained-release drug formulations containing tramadol salts | |
DE69940557D1 (en) | A HYDROCOLLOID AND A DELIVERY-RELATED TABLET CONTAINING CELLULOSE ETHER | |
BRPI0015567B8 (en) | compound, pharmaceutical composition, dosage unit form, use of the pharmaceutical composition and method for preparing a pharmaceutical composition | |
BR0009437A (en) | Pre-gelatinized starch in a controlled release formulation | |
AR006678A1 (en) | DERIVATIVES OF TRICYCLIC MACROLIDES, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, USE OF THEM TO PREPARE MEDICINES AND PROCEDURE FOR THEIR PREPARATION | |
WO2005065069A3 (en) | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease | |
NO330947B1 (en) | The use of oxcarbazepine-containing pharmaceutical compositions in the fasted state | |
AR007040A1 (en) | Erythromycin 6-0-SUBSTITUTED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, USE OF SUCH COMPOUNDS TO PREPARE MEDICINES AND PROCEDURE FOR SUPREPARATION | |
ES2061252T3 (en) | ANTITUSIVE AGENT AND REGULATOR OF THE MUCOSA, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT. | |
AR020001A1 (en) | ACTIVATING COMPOUNDS OF hPPARGAMMA AND hPPARALFA, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD FOR THE TREATMENT AND / OR PREVENTION OF A DISEASE MEDIATED BY THE SAME, AND ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
BRPI0518266A2 (en) | modified-release oral medicinal product of at least one active ingredient in multi-capsule form | |
SE9901573D0 (en) | New compounds | |
BR0209283A (en) | Method for the manufacture of a low dosage pharmaceutical composition having uniform drug distribution and potency | |
BR0211198A (en) | Pharmaceutical compositions and their use | |
HUP0301390A2 (en) | Oral pharmaceutical composition containing valsartan | |
BR9809268A (en) | Pharmaceutical dosage unit, process for manufacturing it, and use of a starch product as a carrier for pharmaceutical dosage units comprising tibolone | |
KR970032872A (en) | Drugs for the treatment of skin damage containing acetylsalicylic acid | |
BR0111051A (en) | Pharmaceutical product and daily pharmaceutical dose for administration to a patient, dose regimen providing an anti-androgenic effect and an antiestrogenic effect on a patient, use of a compound and tamoxifen or a pharmaceutically acceptable salt or solvate thereof, and, method for providing an anti-androgenic effect in a patient | |
AR035006A1 (en) | DERIVATIVE OF NAFTIRIDIN-DIBENZO [A, D] CICLOHEPTENO-10-ACETICO, PHARMACEUTICAL COMPOSITION, AND THE USE OF THAT DERIVATIVE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT. | |
HUP0300863A2 (en) | N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide, process for producing it and pharmaceutical composition containing it | |
SE9901572D0 (en) | New compounds | |
BR0010449A (en) | 14beta-h-sterols, pharmaceutical compositions comprising the same and use of these derivatives for the preparation of meiosis regulating drugs | |
ATE236885T1 (en) | HYDRAZONO-BENZAZULENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND INTERMEDIATE PRODUCTS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |